Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184737 · ClinicalTrials.gov registry record · NA
iSIPsmarter: A Pilot RCT to Evaluate a Web-based Behavioral Intervention to Reduce Sugary Beverages Among Black Adults
A NA study of Diet Habit and Sugar-Sweetened Beverages, sponsored by University of Virginia.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06184737: Active NA study of Diet Habit and Sugar-Sweetened Beverages, sponsored by University of Virginia.
NCT06184737 is a NA study of Diet Habit and Sugar-Sweetened Beverages that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 24 participants, below the 11,775-participant average among 22 other Diet Habit trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06184737, a NA study of Diet Habit and Sugar-Sweetened Beverages, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot randomized controlled trial (RCT) will enroll 24 Black adults. The overall goal is to examine the preliminary efficacy of iSIPsmarter in a 2 group \[iSIPsmarter vs. static Patient Education (PE) website\] by 4 assessment (Pre, 3-, 6- and 18-month follow-up) design. The generated pilot data will allow us to better understand efficacy and engagement outcomes among Black participants. We anticipate trends that iSIPsmarter will be more efficacious at reducing SSB consumption than a PE website at post assessment.
Primary Outcome
Measured using the Beverage Questionnaire 15 (BEVQ-15)
Conditions Studied
Interventions
- BEHAVIORAL iSIPsmarter
- BEHAVIORAL Patient Education (PE)
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-01-12 |
| Est. Completion | 2026-03-17 |
| Phase | NA |
What the registry record for NCT06184737 still lists
NCT06184737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 11,775-participant average among 22 other Diet Habit trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Diet Habit appearing as the primary indexed condition, and to 2 interventions - of which iSIPsmarter is the first listed.
NCT06184737 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06184737 about?
NCT06184737 is a clinical study titled "iSIPsmarter: A Pilot RCT to Evaluate a Web-based Behavioral Intervention to Reduce Sugary Beverages Among Black Adults". The proposed pilot randomized controlled trial (RCT) will enroll 24 Black adults. The overall goal is to examine the preliminary efficacy of iSIPsmarter in a 2 group \[iSIPsmarter vs. static Patient Education (PE) website\] by 4 assessment (Pre, 3-, 6- and 18-month follow-up) design. The generated p...
What is the current status of trial NCT06184737?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-01-12. Estimated completion is 2026-03-17.
What conditions does trial NCT06184737 study?
This clinical trial studies the following conditions: Diet Habit, Sugar-Sweetened Beverages.
What interventions are being tested in trial NCT06184737?
The interventions under investigation include: iSIPsmarter (BEHAVIORAL), Patient Education (PE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06184737?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184737 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diet Habit
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06184737's enrollment target sits among peer trials
24 23rd of 22 the lowest of 22 other Diet Habit trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diet Habit trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
-
Project humAn dieTary daTa rEtuRN
RECRUITING · NA
-
Building Access to Food Through Systems and Solidarity
RECRUITING · NA
-
Personalized Responses to Dietary Composition Trial 3
RECRUITING · NA
-
Walnuts and Colon Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI